A novel core technology known as electric field-induced release and measurement relies on a multiplexible electrochemical sensor that can detect EGFR mutations in bodily fluids was shown to be effective, accurate, rapid and cost-effective for the detection of EGFR mutations in the saliva of patients with NSCLC.47 In addition, Xiao et al.48 found 16 candidate proteins that can discriminate lung cancer patients from healthy individuals and are effective biomarkers with a high sensitivity and specificity. Here, EGFR is linked to lung carcinoma.